Waiting
Processando Login

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Bioengineering / A Combined 3D Tissue Engineered In Vitro/In…
JoVE Journal
Bioengineering

É necessário ter uma assinatura JoVE para assistir este Faça login ou comece sua avaliação gratuita.

JoVE Journal Bioengineering
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
 

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Article DOI: 10.3791/53885-v • 13:34 min • April 6th, 2016
April 6th, 2016 •
*1, *1, *3, 1, 1,4, 2, 3, 1,4, 1
1Department of Tissue Engineering and Regenerative Medicine (TERM), University Hospital Wuerzburg, 2Department of Cardiothoracic Surgery, University Hospital Wuerzburg, 3Department of Bioinformatics, University Wuerzburg, 4Translational Center Wuerzburg, Fraunhofer Institute Interfacial Engineering and Biotechnology IGB
* These authors contributed equally

Capítulos

Resumo
Automatic Translation

We present a three-dimensional (3D) lung cancer model based on a biological collagen scaffold to study sensitivity towards non-small-cell-lung-cancer-(NSCLC)-targeted therapies. We demonstrate different read-out techniques to determine the proliferation index, apoptosis and epithelial-mesenchymal transition (EMT) status. Collected data are integrated into an in silico model for prediction of drug sensitivity.

Tags

Keywords: 3D Tissue Engineering In Vitro In Silico Lung Tumor Model Drug Effectiveness Mutational Backgrounds Non-small Cell Lung Cancer Targeted Therapies Cell-specific Responses Pre-clinical Drug Testing Tumor Entities Drug Response Predictions Bioreactor Gefitinib ELISA Ki67 Staining
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter